2026年4月10日，两高发布《关于办理贪污贿赂刑事案件适用法律若干问题的解释（二）》，5月1日起实施。这份文件对很多行业来说只是一次法律更新，但对医疗行业而言，它几乎意味着一个时代的结束。过去那种“灰色空间尚存、规则模糊不清”的阶段，正在被彻底关上。文件中最直接的一点是：在医疗领域，个人收受或给予回扣，累计达到3万元，就可能触及刑事责任。这3万元不只是现金，还包括购物卡、礼品、旅游、子女教育资助、所谓“学术推广费”等各种变相利益输送。换句话说，曾经游走在灰色地带、可以“心照不宣”的东西，现在被明确纳入法律边界之内，而且是刑事边界。很多年轻医生其实对“回扣”已经很陌生了，这一代人是在集采、DRG和强监管的环境中成长起来的。但如果回头看上一代医生，就会发现，医疗回扣曾经并不罕见。从骨科到检验科，从设备到耗材，动辄几百万、上千万甚至上亿的案件，并不是个例。那为什么会出现这样的现象？答案其实并不复杂。它不是因为医生天生贪婪，而是一个特定历史阶段的产物。过去药品和耗材存在加成，价格虚高，医院和医生的收入结构又长期不合理，基本工资偏低，绩效体系不完善。在这种情况下，一部分灰色收入，客观上成为了一种“补偿机制”。它当然不合法，也不正当，但它确实和当时的制度环境紧密相关。现在，这一整套环境已经发生了根本变化。集采大幅压缩药品和耗材价格，DRG控制过度医疗，《解释（二）》直接将回扣入刑，最后一块灰色空间被彻底切断。过去那种依赖“边缘收益”的模式，已经没有任何生存空间。问题也随之而来：规则变了，收入结构有没有同步改变？如果看一组现实数据，会发现一个不太被公开讨论的事实。以一线城市为例，官方统计中临床医生的年收入中位数在十几万元左右，住院医生甚至只有几万元，而且这是税前收入。一个医学生从本科到规培结束，往往接近30岁才真正开始稳定工作，家庭教育投入动辄几十万甚至上百万元。在这样的投入产出比之下，医生这份职业，本身就不算一个“高回报职业”。所以，当灰色收入被彻底清零之后，很多人真正担心的，并不是“不能拿回扣”，而是如果阳光收入没有跟上，这个职业还值不值得坚持？受影响最大的，其实不是那些已经完成原始积累的“前浪”，而是刚刚入行的年轻医生。规则在他们进入牌桌的时候已经改变，但新的分配机制还没有完全建立。尤其是儿科、急诊、产科这些本就高强度、低回报的科室，如果收入和付出长期不匹配，未来的人才供给一定会受到影响。但换一个角度看，这次变化本身是必要的。

医疗回扣，本质上伤害的是患者信任，也扭曲了医疗决策。一个医生如果在用药、用耗材、选择手术方案时受到利益驱动，那最终承担风险的是病人。对绝大多数守规矩、靠本事吃饭的医生来说，清理灰色空间，其实是一次“清理环境”的过程。问题变成了一个更现实的选择题：在一个没有灰色收入的行业里，医生靠什么让自己过得更好。答案其实也很直接。第一，是能力。无论制度如何变化，医疗行业最终还是一个“能力至上”的行业。你的手术做得如何，你的判断是否可靠，你能不能解决别人解决不了的问题，这些才是你长期收入的基础。过去可以靠信息差、渠道、关系获取额外收益的空间在消失，真正决定价值的，只会是技术本身。第二，是结构。医生的收入，不会只来自“看门诊”和“做手术”。科研、教学、学术影响力、国际合作、学科建设，这些都会逐渐成为收入和资源分配的一部分。单一依赖临床工作，很难在未来的体系中获得更高回报。第三是环境。平台的差异会越来越明显。你所在的医院、科室、团队，决定了你能接触到什么样的资源。有的医院开始探索年薪制，有的科室分配机制更透明，有的团队愿意给年轻人空间。一个有规范管理、有合理分配机制的团队，远比一个“名气大但内部分配混乱”的单位更重要。与此同时，还有一个更宏观的问题，是整个行业必须面对的。如果医生被要求“完全阳光收入”，那这份收入是否足够体面？很多地方已经给出过答案。无论是中国香港，还是欧洲多数国家，医生属于收入较高、社会地位稳定的群体。收入结构清晰，规则明确，当医生的合法收入足够高，就没有必要，也没有动力去触碰灰色甚至违法的边界。这就是所谓的“高薪养廉”。中国医疗正在走到这一步，但还没有完全走到。反腐已经走在前面，薪酬体系的改革却还在路上。年薪制在试点，但覆盖面有限；规培医生收入偏低的问题依然存在；绩效分配机制在不同医院之间差异很大。对于医生个体来说，这个时代确实更难了，但也更清晰了。你不再需要在灰色地带中试探边界，也不需要提心吊胆地担心哪一天被调查。你唯一需要思考的是：在一个完全透明、完全合规的环境里，你的价值在哪里？有些人可能会因此失去动力，觉得“反正赚不到钱了”。但更现实的情况是，行业正在重新洗牌。过去依赖灰色收入的人，会被淘汰；而真正有能力、有判断力、有长期规划的人，反而会在新的规则下脱颖而出。医疗从来不是一个可以靠“捷径”长期生存的行业。当所有捷径都被封死，剩下的，才是真正的路。

On April 10, 2026, the Supreme People’s Court of the People’s Republic of China and the Supreme People’s Procuratorate of the People's Republic of China issued the Judicial Interpretation (II) on the Application of Law in Handling Embezzlement and Bribery Criminal Cases, which shall come into force on May 1. For most industries, this document is merely a routine legal update. But for the healthcare industry, it virtually marks the end of an era. The past phase, in which gray areas still existed and rules remained unclear, is now being completely closed off. The most direct provision is clear: within the medical sector, any individual who solicits, accepts or offers kickbacks involving a cumulative amount of 30,000 Chinese yuan may face criminal liability. The 30,000 Chinese yuan covers not only cash, but also shopping cards, gifts, travel, subsidies for children’s education, and so-called “academic promotion fees,” as well as various other forms of disguised interest transfer. In other words, activities that once existed in regulatory gray zones and were implicitly tolerated have now been explicitly brought within legal boundaries, in particular under criminal law. Many younger doctors today are, in fact, quite unfamiliar with the notion of “kickbacks.” This generation has grown up under national centralized procurement, DRG-based payment systems, and a framework of strict regulation. However, looking back at the previous generation, it becomes clear that medical kickbacks were once far from uncommon. From orthopedics to laboratory medicine, and from medical equipment to consumables, cases involving hundreds of thousands, millions, or even hundreds of millions were not isolated incidents. Why did such phenomena emerge? The answer is straightforward. It stems not from inherent greed among medical professionals, but from the special context of a specific historical period. In the past, medicines and medical consumables were significantly marked up with inflated pricing. Meanwhile, hospitals and doctors long suffered from unreasonable income structures, with low basic salaries and imperfect performance appraisal systems. Under such circumstances, grey income objectively became an informal compensatory mechanism. While undeniably illegal and improper, it was deeply intertwined with the institutional environment of that time. Now, the entire environment has undergone a fundamental transformation. National centralized procurement has significantly reduced the prices of pharmaceuticals and medical consumables, DRG-based payment systems have curbed excessive treatment, and the Judicial Interpretation (II) has explicitly criminalized kickbacks. As a result, the last remaining gray area has been completely eliminated. The former model relying on “marginal gains” no longer has any room to survive. This inevitably raises another question: as the rules have changed, has the income structure changed accordingly? If we look at real-world data, an often under-discussed fact becomes apparent. Taking first-tier cities as an example, official statistics show that the median annual income of clinical physicians is only in the range of around a hundred thousand yuan, while residents may earn just tens of thousands, and these figures are pre-tax. A medical student, from undergraduate study through residency training, often does not begin stable employment until close to the age of 30, with family educational investment easily reaching hundreds of thousands or even over a million yuan. Given this input–output ratio, the medical profession cannot, by itself, be regarded as a high-return profession. Therefore, when gray income has been completely eliminated, what many people are truly concerned about is not the loss of kickbacks per se, but rather whether this profession is still worth pursuing if legitimate income fails to keep pace. Those most affected are not senior doctors who have already accumulated wealth and career capital, but young practitioners just starting out. They enter the profession under tightened new rules, while a fair new income distribution system is yet to be fully established. This is especially true for high-intensity, low-remuneration departments such as pediatrics, emergency medicine and obstetrics. If workload and compensation remain mismatched in the long run, future talent supply will inevitably be affected. But from another perspective, this change itself is necessary. Medical kickbacks fundamentally undermine patient trust and distort clinical decision-making. When physicians’ choices of medication, consumables, or surgical approaches are influenced by financial incentives, the ultimate risk is borne by patients. For the vast majority of law-abiding doctors who rely on their professional competence, the elimination of gray areas is, in fact, a process of “improving the clinical environment.” This leaves a more practical choice: in a system without gray income, what can doctors rely on to improve their living standards? The answer is actually quite straightforward. First, it is competence. Regardless of how the system changes, medicine ultimately remains a field where capability prevails. The quality of your surgical performance, the reliability of your clinical judgment, and your ability to solve problems that others cannot, these are what fundamentally determine your long-term income. The space for earning additional gains through information asymmetry, channels, or relationships is disappearing. Ultimately, what truly determines value is technical skill itself. Second, it is about income structure. A doctor’s income does not only come from outpatient consultations and surgical operations. Research, teaching, academic influence, international cooperation and specialty construction will gradually become part of income and resource allocation. Relying solely on clinical work makes it difficult to gain higher returns within the future system. Third, the working environment. The gap between different professional platforms will become increasingly apparent. The hospital, department and team you belong to determine the resources you can access. Some hospitals have begun to adopt an annual salary system. Some departments feature a more transparent income distribution mechanism. And some teams are willing to offer development opportunities to young doctors. A team with standardized management and a reasonable distribution system is far more valuable than an institution with a prestigious reputation yet chaotic internal benefit allocation. Meanwhile, the entire industry faces a broader macro challenge. If doctors are required to rely entirely on legitimate transparent income, is such income sufficient to provide a dignified standard of living? Many places have already provided an answer to this question. Whether in Hong Kong, China, or in most European countries, doctors generally belong to a group with relatively high incomes and stable social status. Their income structures are transparent and the rules are clearly defined. When doctors’ legitimate earnings are sufficiently high, there is neither the need nor the incentive to cross into gray areas or even illegal boundaries. This is the logic behind the principle of “high salaries promoting integrity.” China’s healthcare system is moving in this direction, but has not fully arrived there yet. Anti-corruption efforts have advanced ahead, while reforms of the compensation system are still underway. The annual salary system is currently under pilot implementation but covers only a limited number of institutions. The issue of low income among standardized training residents remains unresolved. Besides, there are huge disparities in performance-based allocation mechanisms across different hospitals. For individual doctors, this era has indeed become more challenging, yet the path ahead has never been clearer. There is no longer any need to test the boundaries of gray areas, nor live in constant fear of investigation. The only question to consider is: in a fully transparent, fully compliant professional environment, where lies your core value? Some people may lose their motivation as a result, thinking "there is no way to make good money anyway". The more realistic truth, however, is that the industry is undergoing reshuffling. Those who once relied on gray income will be eliminated. By contrast, professionals with real competence, sound judgment and long-term planning will stand out under the new rules. Healthcare has never been a profession that can sustain long-term success through shortcuts. When all shortcuts are blocked, what remains is the true path.